The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/85321
CoreRx, Inc Clearwater, FL www.corerxpharma.com (727) 259-6950 DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Capsules, controlled substances, creams & ointments, gels, generics, injectables, liquids, lyophilized products, non-sterile, ophthalmics, OTC, parenterals (large volume), parenterals (small volume), powders (non-sterile), semisolids, soft gels, solid dose, solutions & suspensions, sustained release, syringes (pre-filled), and topicals. "CoreRx is proud to be recognized by our clients for the CMO Leadership Award in productivity. We strive to exceed industry standards by providing unparalleled levels of customer service, reliability, and quality across all platforms. Our move to a new 35,000 sq. ft. cGMP facility has enabled CoreRx's scientific staff to custom formulate, analyze, and manufacture the highest quality pharmaceutical products for their client-partners. Our strong customer-centric approach, coupled with the highest technical/ scientific and quality services, has enabled us to grow into one of the most respectable in the industry." — Todd R. Daviau, Ph.D., president & CEO Dalton Pharma Services Toronto, Ontario, Canada www.dalton.com (416) 661-2102 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Manufacturing location: Toronto, Canada Contact: Kevin McCarthy, assoc. director, sales & marketing chemist@dalton.com DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, and packaging SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, creams & ointments, generics, injectables, liquids, lyophilized products, non-sterile, ophthalmics, OTC, parenterals (large volume), parenterals (small volume), peptides, powders (non-sterile), powders (sterile), proteins, semisolids, solid dose, solutions & suspensions, sterile, sustained release, syringes (pre-filled), topicals, and vaccines. "Since Dalton's inception 26 years ago, we have challenged ourselves to find innovative ways to achieve our clients' goals. This has included applying innovative thinking to business deals as well as developing novel processes and products. Dalton's role is to enhance the success of our customers by delivering cutting edge science and exceptional customer service. Innovation is at the core of everything we do at Dalton." — Peter Pekos, president and CEO 38 The CMO Leadership Awards 2012 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical, clinical (phase 1, phase 2, and phase 3) Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, controlled substances, creams & ointments, gels, generics, liquids, lotions, non-sterile, ointments, ophthalmics, OTC, peptides, proteins, semisolids, solutions & suspensions, sterile, topicals, and vaginal applicators. "Dow is very pleased to receive these awards. We are honored to be recognized for our efforts and to be highlighted as a premier semi-solid and liquid product development company. We have focused on meeting and exceeding our customers' expectations for more than 34 years. Being acknowledged for innovation, reliability, and regulatory, speaks not only to our exceptional technical expertise, but to the quality service our entire organization provides to our clients." — Karen Yu, Ph.D., general manager Manufacturing location: Clearwater, FL Contact: Jenna Leitao jenna.leitao@corerxpharma.com DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, injectables, liquids, parenterals (large volume), proteins, sterile, and vaccines. "We are honored to be recognized by our clients as a liquid dose manufacturing leader for reliability. Cytovance Biologics takes pride in being a reliable, value-added partner with our clients in providing integral pathways of converting today's novel protein discoveries into future life- saving therapies. This award is possible thanks to our highly experienced employees who consistently demonstrate commitment to service. We accept this award as a testament to the dedication and hard work of many within our remarkable company." — Darren Head, president and chief executive officer Dow Pharmaceutical Sciences Petaluma, CA www.dowpharmsci.com (707) 937-2600 Manufacturing location: Petaluma, CA Contact: Karen Hanley, director of business development karen.hanley@dowpharmsci.com DRUG TYPE: Biopharmaceuticals Cytovance Biologics, Inc. Oklahoma City, OK www.cytovance.com PH: (405) 319-8310 Manufacturing location: Oklahoma City, OK Contact: Valerie McDonnell vmcdonnell@cytovance.com DRUG LIFE CYCLE STAGES